Evidence map›Paper›PMID 25190252›Full record

ReviewCold Spring Harbor perspectives in medicine2014

Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches.

Stefan Niemann, Philip Supply

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Tuberculosis: An Ongoing Global Threat.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. Genetic diversity and antibiotic resistance ofFrontiers in cellular and infection microbiology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pan-genome association study ofFrontiers in microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Genomic Investigation of aThe American journal of tropical medicine and hygiene · 2018
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stefan NiemannMolecular Mycobacteriology, Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, 23845 Borstel, Germany German Center for Infection Research (DZIF), partner site Borstel, 23845 Borstel, Germany.
Philip SupplyInstitut National de la Santé et de la Recherche Medicalé (INSERM) U1019, 59019 Lille, France Centre National de la Recherche Scientifique (CNRS) UMR 8204, 59019 Lille, France Institut Pasteur de Lille, Center for Infection and Immunity of Lille, 59019 Lille, France Université Lille Nord de France, 59019 Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genotyping of clinical Mycobacterium tuberculosis complex (MTBC) strains has become a standard tool for epidemiological tracing and for the investigation of the local and global strain population structure. Of special importance is the analysis of the expansion of multidrug (MDR) and extensively drug-resistant (XDR) strains. Classical genotyping and, more recently, whole-genome sequencing have revealed that the strains of the MTBC are more diverse than previously anticipated. Globally, several phylogenetic lineages can be distinguished whose geographical distribution is markedly variable. Strains of particular (sub)lineages, such as Beijing, seem to be more virulent and associated with enhanced resistance levels and fitness, likely fueling their spread in certain world regions. The upcoming generalization of whole-genome sequencing approaches will expectedly provide more comprehensive insights into the molecular and epidemiological mechanisms involved and lead to better diagnostic and therapeutic tools.

Indexed as

Genotyping TechniquesAntitubercular AgentsBiodiversityDrug Resistance, BacterialEvolution, MolecularGenetic VariationGenome, BacterialHumansMolecular EpidemiologyMycobacterium tuberculosisPolymerase Chain ReactionTuberculosis, PulmonaryAntitubercular Agents

Identifiers

PMID25190252
PMCPMC4292095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.